ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiopulmonary Autotransfusion Systems Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-13F8812
Home | Market Reports | Health| Medical Devices & Equipment
China Cardiopulmonary Autotransfusion Systems Market Report Forecast 2021 2027
BUY CHAPTERS

Global Cardiopulmonary Autotransfusion Systems Market Research Report 2025

Code: QYRE-Auto-13F8812
Report
August 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic Inc
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker

Cardiopulmonary Autotransfusion Systems Market Size

The global market for Cardiopulmonary Autotransfusion Systems was valued at US$ 581 million in the year 2024 and is projected to reach a revised size of US$ 684 million by 2031, growing at a CAGR of 2.4% during the forecast period.

Cardiopulmonary Autotransfusion Systems Market

Cardiopulmonary Autotransfusion Systems Market

Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one"s self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion Systems.
The Cardiopulmonary Autotransfusion Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiopulmonary Autotransfusion Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Autotransfusion Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cardiopulmonary Autotransfusion Systems Market Report

Report Metric Details
Report Name Cardiopulmonary Autotransfusion Systems Market
Accounted market size in year US$ 581 million
Forecasted market size in 2031 US$ 684 million
CAGR 2.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Unwashed ATS
  • Washed ATS
Segment by Application
  • Heart Surgery
  • Great Organ Transplant Surgery
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Atrium Medical, Global Blood Resources, Redax, Sarstedt, Stryker
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cardiopulmonary Autotransfusion Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cardiopulmonary Autotransfusion Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Cardiopulmonary Autotransfusion Systems Market growing?

Ans: The Cardiopulmonary Autotransfusion Systems Market witnessing a CAGR of 2.4% during the forecast period 2025-2031.

What is the Cardiopulmonary Autotransfusion Systems Market size in 2031?

Ans: The Cardiopulmonary Autotransfusion Systems Market size in 2031 will be US$ 684 million.

Who are the main players in the Cardiopulmonary Autotransfusion Systems Market report?

Ans: The main players in the Cardiopulmonary Autotransfusion Systems Market are Advancis Surgical, Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo, Atrium Medical, Global Blood Resources, Redax, Sarstedt, Stryker

What are the Application segmentation covered in the Cardiopulmonary Autotransfusion Systems Market report?

Ans: The Applications covered in the Cardiopulmonary Autotransfusion Systems Market report are Heart Surgery, Great Organ Transplant Surgery, Others

What are the Type segmentation covered in the Cardiopulmonary Autotransfusion Systems Market report?

Ans: The Types covered in the Cardiopulmonary Autotransfusion Systems Market report are Unwashed ATS, Washed ATS

1 Cardiopulmonary Autotransfusion Systems Market Overview
1.1 Product Definition
1.2 Cardiopulmonary Autotransfusion Systems by Type
1.2.1 Global Cardiopulmonary Autotransfusion Systems Market Value Comparison by Type (2024 VS 2031)
1.2.2 Unwashed ATS
1.2.3 Washed ATS
1.3 Cardiopulmonary Autotransfusion Systems by Application
1.3.1 Global Cardiopulmonary Autotransfusion Systems Market Value by Application (2024 VS 2031)
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Others
1.4 Global Cardiopulmonary Autotransfusion Systems Market Size Estimates and Forecasts
1.4.1 Global Cardiopulmonary Autotransfusion Systems Revenue 2020-2031
1.4.2 Global Cardiopulmonary Autotransfusion Systems Sales 2020-2031
1.4.3 Global Cardiopulmonary Autotransfusion Systems Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cardiopulmonary Autotransfusion Systems Market Competition by Manufacturers
2.1 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cardiopulmonary Autotransfusion Systems Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cardiopulmonary Autotransfusion Systems, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Product Type & Application
2.7 Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Date of Enter into This Industry
2.8 Global Cardiopulmonary Autotransfusion Systems Market Competitive Situation and Trends
2.8.1 Global Cardiopulmonary Autotransfusion Systems Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cardiopulmonary Autotransfusion Systems Players Market Share by Revenue
2.8.3 Global Cardiopulmonary Autotransfusion Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cardiopulmonary Autotransfusion Systems Market Scenario by Region
3.1 Global Cardiopulmonary Autotransfusion Systems Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cardiopulmonary Autotransfusion Systems Sales by Region: 2020-2031
3.2.1 Global Cardiopulmonary Autotransfusion Systems Sales by Region: 2020-2025
3.2.2 Global Cardiopulmonary Autotransfusion Systems Sales by Region: 2026-2031
3.3 Global Cardiopulmonary Autotransfusion Systems Revenue by Region: 2020-2031
3.3.1 Global Cardiopulmonary Autotransfusion Systems Revenue by Region: 2020-2025
3.3.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Region: 2026-2031
3.4 North America Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Country
3.4.1 North America Cardiopulmonary Autotransfusion Systems Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cardiopulmonary Autotransfusion Systems Sales by Country (2020-2031)
3.4.3 North America Cardiopulmonary Autotransfusion Systems Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Country
3.5.1 Europe Cardiopulmonary Autotransfusion Systems Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cardiopulmonary Autotransfusion Systems Sales by Country (2020-2031)
3.5.3 Europe Cardiopulmonary Autotransfusion Systems Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Region
3.6.1 Asia Pacific Cardiopulmonary Autotransfusion Systems Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cardiopulmonary Autotransfusion Systems Sales by Region (2020-2031)
3.6.3 Asia Pacific Cardiopulmonary Autotransfusion Systems Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Country
3.7.1 Latin America Cardiopulmonary Autotransfusion Systems Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cardiopulmonary Autotransfusion Systems Sales by Country (2020-2031)
3.7.3 Latin America Cardiopulmonary Autotransfusion Systems Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiopulmonary Autotransfusion Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiopulmonary Autotransfusion Systems Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cardiopulmonary Autotransfusion Systems Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cardiopulmonary Autotransfusion Systems Sales by Type (2020-2031)
4.1.1 Global Cardiopulmonary Autotransfusion Systems Sales by Type (2020-2025)
4.1.2 Global Cardiopulmonary Autotransfusion Systems Sales by Type (2026-2031)
4.1.3 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Type (2020-2031)
4.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Type (2020-2031)
4.2.1 Global Cardiopulmonary Autotransfusion Systems Revenue by Type (2020-2025)
4.2.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Type (2026-2031)
4.2.3 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2020-2031)
4.3 Global Cardiopulmonary Autotransfusion Systems Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cardiopulmonary Autotransfusion Systems Sales by Application (2020-2031)
5.1.1 Global Cardiopulmonary Autotransfusion Systems Sales by Application (2020-2025)
5.1.2 Global Cardiopulmonary Autotransfusion Systems Sales by Application (2026-2031)
5.1.3 Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Application (2020-2031)
5.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Application (2020-2031)
5.2.1 Global Cardiopulmonary Autotransfusion Systems Revenue by Application (2020-2025)
5.2.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Application (2026-2031)
5.2.3 Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Application (2020-2031)
5.3 Global Cardiopulmonary Autotransfusion Systems Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Advancis Surgical
6.1.1 Advancis Surgical Company Information
6.1.2 Advancis Surgical Description and Business Overview
6.1.3 Advancis Surgical Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Advancis Surgical Cardiopulmonary Autotransfusion Systems Product Portfolio
6.1.5 Advancis Surgical Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Company Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Haemonetics
6.3.1 Haemonetics Company Information
6.3.2 Haemonetics Description and Business Overview
6.3.3 Haemonetics Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Haemonetics Cardiopulmonary Autotransfusion Systems Product Portfolio
6.3.5 Haemonetics Recent Developments/Updates
6.4 LivaNova
6.4.1 LivaNova Company Information
6.4.2 LivaNova Description and Business Overview
6.4.3 LivaNova Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.4.4 LivaNova Cardiopulmonary Autotransfusion Systems Product Portfolio
6.4.5 LivaNova Recent Developments/Updates
6.5 Medtronic
6.5.1 Medtronic Company Information
6.5.2 Medtronic Description and Business Overview
6.5.3 Medtronic Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Medtronic Cardiopulmonary Autotransfusion Systems Product Portfolio
6.5.5 Medtronic Recent Developments/Updates
6.6 Terumo
6.6.1 Terumo Company Information
6.6.2 Terumo Description and Business Overview
6.6.3 Terumo Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Terumo Cardiopulmonary Autotransfusion Systems Product Portfolio
6.6.5 Terumo Recent Developments/Updates
6.7 Atrium Medical
6.7.1 Atrium Medical Company Information
6.7.2 Atrium Medical Description and Business Overview
6.7.3 Atrium Medical Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Atrium Medical Cardiopulmonary Autotransfusion Systems Product Portfolio
6.7.5 Atrium Medical Recent Developments/Updates
6.8 Global Blood Resources
6.8.1 Global Blood Resources Company Information
6.8.2 Global Blood Resources Description and Business Overview
6.8.3 Global Blood Resources Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Global Blood Resources Cardiopulmonary Autotransfusion Systems Product Portfolio
6.8.5 Global Blood Resources Recent Developments/Updates
6.9 Redax
6.9.1 Redax Company Information
6.9.2 Redax Description and Business Overview
6.9.3 Redax Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Redax Cardiopulmonary Autotransfusion Systems Product Portfolio
6.9.5 Redax Recent Developments/Updates
6.10 Sarstedt
6.10.1 Sarstedt Company Information
6.10.2 Sarstedt Description and Business Overview
6.10.3 Sarstedt Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sarstedt Cardiopulmonary Autotransfusion Systems Product Portfolio
6.10.5 Sarstedt Recent Developments/Updates
6.11 Stryker
6.11.1 Stryker Company Information
6.11.2 Stryker Description and Business Overview
6.11.3 Stryker Cardiopulmonary Autotransfusion Systems Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Stryker Cardiopulmonary Autotransfusion Systems Product Portfolio
6.11.5 Stryker Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiopulmonary Autotransfusion Systems Industry Chain Analysis
7.2 Cardiopulmonary Autotransfusion Systems Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiopulmonary Autotransfusion Systems Production Mode & Process Analysis
7.4 Cardiopulmonary Autotransfusion Systems Sales and Marketing
7.4.1 Cardiopulmonary Autotransfusion Systems Sales Channels
7.4.2 Cardiopulmonary Autotransfusion Systems Distributors
7.5 Cardiopulmonary Autotransfusion Systems Customer Analysis
8 Cardiopulmonary Autotransfusion Systems Market Dynamics
8.1 Cardiopulmonary Autotransfusion Systems Industry Trends
8.2 Cardiopulmonary Autotransfusion Systems Market Drivers
8.3 Cardiopulmonary Autotransfusion Systems Market Challenges
8.4 Cardiopulmonary Autotransfusion Systems Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Advancis Surgical
Fresenius Kabi
Haemonetics
LivaNova
Medtronic Inc
Terumo
Atrium Medical
Global Blood Resources
Redax
Sarstedt
Stryker
List of Tables
 Table 1. Global Cardiopulmonary Autotransfusion Systems Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cardiopulmonary Autotransfusion Systems Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cardiopulmonary Autotransfusion Systems Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cardiopulmonary Autotransfusion Systems Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cardiopulmonary Autotransfusion Systems Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cardiopulmonary Autotransfusion Systems Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cardiopulmonary Autotransfusion Systems Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cardiopulmonary Autotransfusion Systems, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Product Type & Application
 Table 12. Global Key Manufacturers of Cardiopulmonary Autotransfusion Systems, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cardiopulmonary Autotransfusion Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion Systems as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cardiopulmonary Autotransfusion Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cardiopulmonary Autotransfusion Systems Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Region (2020-2025)
 Table 19. Global Cardiopulmonary Autotransfusion Systems Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Region (2026-2031)
 Table 21. Global Cardiopulmonary Autotransfusion Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Region (2020-2025)
 Table 23. Global Cardiopulmonary Autotransfusion Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Region (2026-2031)
 Table 25. North America Cardiopulmonary Autotransfusion Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cardiopulmonary Autotransfusion Systems Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cardiopulmonary Autotransfusion Systems Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cardiopulmonary Autotransfusion Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cardiopulmonary Autotransfusion Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cardiopulmonary Autotransfusion Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cardiopulmonary Autotransfusion Systems Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cardiopulmonary Autotransfusion Systems Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cardiopulmonary Autotransfusion Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cardiopulmonary Autotransfusion Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cardiopulmonary Autotransfusion Systems Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cardiopulmonary Autotransfusion Systems Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cardiopulmonary Autotransfusion Systems Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cardiopulmonary Autotransfusion Systems Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cardiopulmonary Autotransfusion Systems Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cardiopulmonary Autotransfusion Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cardiopulmonary Autotransfusion Systems Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cardiopulmonary Autotransfusion Systems Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cardiopulmonary Autotransfusion Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cardiopulmonary Autotransfusion Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cardiopulmonary Autotransfusion Systems Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cardiopulmonary Autotransfusion Systems Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cardiopulmonary Autotransfusion Systems Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cardiopulmonary Autotransfusion Systems Sales (K Units) by Type (2020-2025)
 Table 51. Global Cardiopulmonary Autotransfusion Systems Sales (K Units) by Type (2026-2031)
 Table 52. Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Type (2020-2025)
 Table 53. Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Type (2026-2031)
 Table 54. Global Cardiopulmonary Autotransfusion Systems Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cardiopulmonary Autotransfusion Systems Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2020-2025)
 Table 57. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Type (2026-2031)
 Table 58. Global Cardiopulmonary Autotransfusion Systems Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Cardiopulmonary Autotransfusion Systems Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Cardiopulmonary Autotransfusion Systems Sales (K Units) by Application (2020-2025)
 Table 61. Global Cardiopulmonary Autotransfusion Systems Sales (K Units) by Application (2026-2031)
 Table 62. Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Application (2020-2025)
 Table 63. Global Cardiopulmonary Autotransfusion Systems Sales Market Share by Application (2026-2031)
 Table 64. Global Cardiopulmonary Autotransfusion Systems Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cardiopulmonary Autotransfusion Systems Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Application (2020-2025)
 Table 67. Global Cardiopulmonary Autotransfusion Systems Revenue Market Share by Application (2026-2031)
 Table 68. Global Cardiopulmonary Autotransfusion Systems Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Cardiopulmonary Autotransfusion Systems Price (USD/Unit) by Application (2026-2031)
 Table 70. Advancis Surgical Company Information
 Table 71. Advancis Surgical Description and Business Overview
 Table 72. Advancis Surgical Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Advancis Surgical Cardiopulmonary Autotransfusion Systems Product
 Table 74. Advancis Surgical Recent Developments/Updates
 Table 75. Fresenius Kabi Company Information
 Table 76. Fresenius Kabi Description and Business Overview
 Table 77. Fresenius Kabi Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Fresenius Kabi Cardiopulmonary Autotransfusion Systems Product
 Table 79. Fresenius Kabi Recent Developments/Updates
 Table 80. Haemonetics Company Information
 Table 81. Haemonetics Description and Business Overview
 Table 82. Haemonetics Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Haemonetics Cardiopulmonary Autotransfusion Systems Product
 Table 84. Haemonetics Recent Developments/Updates
 Table 85. LivaNova Company Information
 Table 86. LivaNova Description and Business Overview
 Table 87. LivaNova Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. LivaNova Cardiopulmonary Autotransfusion Systems Product
 Table 89. LivaNova Recent Developments/Updates
 Table 90. Medtronic Company Information
 Table 91. Medtronic Description and Business Overview
 Table 92. Medtronic Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Medtronic Cardiopulmonary Autotransfusion Systems Product
 Table 94. Medtronic Recent Developments/Updates
 Table 95. Terumo Company Information
 Table 96. Terumo Description and Business Overview
 Table 97. Terumo Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Terumo Cardiopulmonary Autotransfusion Systems Product
 Table 99. Terumo Recent Developments/Updates
 Table 100. Atrium Medical Company Information
 Table 101. Atrium Medical Description and Business Overview
 Table 102. Atrium Medical Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Atrium Medical Cardiopulmonary Autotransfusion Systems Product
 Table 104. Atrium Medical Recent Developments/Updates
 Table 105. Global Blood Resources Company Information
 Table 106. Global Blood Resources Description and Business Overview
 Table 107. Global Blood Resources Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Global Blood Resources Cardiopulmonary Autotransfusion Systems Product
 Table 109. Global Blood Resources Recent Developments/Updates
 Table 110. Redax Company Information
 Table 111. Redax Description and Business Overview
 Table 112. Redax Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Redax Cardiopulmonary Autotransfusion Systems Product
 Table 114. Redax Recent Developments/Updates
 Table 115. Sarstedt Company Information
 Table 116. Sarstedt Description and Business Overview
 Table 117. Sarstedt Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Sarstedt Cardiopulmonary Autotransfusion Systems Product
 Table 119. Sarstedt Recent Developments/Updates
 Table 120. Stryker Company Information
 Table 121. Stryker Description and Business Overview
 Table 122. Stryker Cardiopulmonary Autotransfusion Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Stryker Cardiopulmonary Autotransfusion Systems Product
 Table 124. Stryker Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Cardiopulmonary Autotransfusion Systems Distributors List
 Table 128. Cardiopulmonary Autotransfusion Systems Customers List
 Table 129. Cardiopulmonary Autotransfusion Systems Market Trends
 Table 130. Cardiopulmonary Autotransfusion Systems Market Drivers
 Table 131. Cardiopulmonary Autotransfusion Systems Market Challenges
 Table 132. Cardiopulmonary Autotransfusion Systems Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cardiopulmonary Autotransfusion Systems
 Figure 2. Global Cardiopulmonary Autotransfusion Systems Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cardiopulmonary Autotransfusion Systems Market Share by Type: 2024 & 2031
 Figure 4. Unwashed ATS Product Picture
 Figure 5. Washed ATS Product Picture
 Figure 6. Global Cardiopulmonary Autotransfusion Systems Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cardiopulmonary Autotransfusion Systems Market Share by Application: 2024 & 2031
 Figure 8. Heart Surgery
 Figure 9. Great Organ Transplant Surgery
 Figure 10. Others
 Figure 11. Global Cardiopulmonary Autotransfusion Systems Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Cardiopulmonary Autotransfusion Systems Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Cardiopulmonary Autotransfusion Systems Sales (2020-2031) & (K Units)
 Figure 14. Global Cardiopulmonary Autotransfusion Systems Average Price (USD/Unit) & (2020-2031)
 Figure 15. Cardiopulmonary Autotransfusion Systems Report Years Considered
 Figure 16. Cardiopulmonary Autotransfusion Systems Sales Share by Manufacturers in 2024
 Figure 17. Global Cardiopulmonary Autotransfusion Systems Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Cardiopulmonary Autotransfusion Systems Players: Market Share by Revenue in Cardiopulmonary Autotransfusion Systems in 2024
 Figure 19. Cardiopulmonary Autotransfusion Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Cardiopulmonary Autotransfusion Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Cardiopulmonary Autotransfusion Systems Sales Market Share by Country (2020-2031)
 Figure 22. North America Cardiopulmonary Autotransfusion Systems Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Cardiopulmonary Autotransfusion Systems Sales Market Share by Country (2020-2031)
 Figure 26. Europe Cardiopulmonary Autotransfusion Systems Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Cardiopulmonary Autotransfusion Systems Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Cardiopulmonary Autotransfusion Systems Revenue Market Share by Region (2020-2031)
 Figure 34. China Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Cardiopulmonary Autotransfusion Systems Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Cardiopulmonary Autotransfusion Systems Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Cardiopulmonary Autotransfusion Systems Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Cardiopulmonary Autotransfusion Systems Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. U.A.E Cardiopulmonary Autotransfusion Systems Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Cardiopulmonary Autotransfusion Systems by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Cardiopulmonary Autotransfusion Systems by Type (2020-2031)
 Figure 56. Global Cardiopulmonary Autotransfusion Systems Price (USD/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Cardiopulmonary Autotransfusion Systems by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Cardiopulmonary Autotransfusion Systems by Application (2020-2031)
 Figure 59. Global Cardiopulmonary Autotransfusion Systems Price (USD/Unit) by Application (2020-2031)
 Figure 60. Cardiopulmonary Autotransfusion Systems Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions